Harnessing the power of miRNA to transform cancer management

MiRXES is a privately held life science research tool provider and miRNA diagnostic test developer headquartered in Singapore. MiRXES was founded by Professor Too Heng-Phon and three like-minded partners in 2014 with the vision of creating accurate, affordable and actionable molecular diagnostic tests to improve cancer management.

Our mission is to

  • Advance miRNA technologies to empower translational R & D
  • Identify novel miRNA disease biomarkers in biofluids and tissues
  • Develop non-invasive cancer screening and diagnostic tests
  • Forging close ties with key partners

    MiRXES is a spin-off from the Bioprocessing Technology Institute of the Agency of Science Technology And Research (A*STAR) and is supported by Exploit Technologies and the National University of Singapore. MiRXES collaborates extensively with academic, clinical and industrial partners locally and globally in advancing the science and business of miRNA. MiRXES is a key partner to Singapore’s National Diagnostic Initiative.

    Scientific Advisory Board